ITGB8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.141800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.732000E-01
Normal-vs-Stage2
2.767400E-01
Normal-vs-Stage3
9.694800E-01
Normal-vs-Stage4
4.833200E-01
Stage1-vs-Stage2
6.360000E-01
Stage1-vs-Stage3
1.330240E-01
Stage1-vs-Stage4
8.915000E-01
Stage2-vs-Stage3
1.985840E-01
Stage2-vs-Stage4
6.256000E-01
Stage3-vs-Stage4
3.332200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.142800E-01
Normal-vs-AfricanAmerican
2.254400E-01
Normal-vs-Asian
3.692600E-01
Caucasian-vs-AfricanAmerican
9.085800E-01
Caucasian-vs-Asian
4.590400E-01
AfricanAmerican-vs-Asian
4.362600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.939800E-01
Normal-vs-Female
3.488000E-01
Male-vs-Female
7.421800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.606600E-01
Normal-vs-Age(41-60Yrs)
1.046830E-01
Normal-vs-Age(61-80Yrs)
4.490200E-01
Normal-vs-Age(81-100Yrs)
6.442800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.238800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.049200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.893000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.996500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.104060E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.772420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.924000E-01
Normal-vs-Daily Drinker
4.827000E-01
Normal-vs-Weekly Drinker
5.143000E-01
Normal-vs-Occasional Drinker
2.540200E-01
Normal-vs-Social Drinker
2.910600E-01
Non Drinker-vs-Daily Drinker
2.148600E-01
Non Drinker-vs-Weekly Drinker
7.956800E-01
Non Drinker-vs-Occasional Drinker
1.367170E-01
Non Drinker-vs-Social Drinker
8.371400E-01
Daily Drinker-vs-Weekly Drinker
5.774200E-01
Daily Drinker-vs-Occasional Drinker
4.000000E-02
Daily Drinker-vs-Social Drinker
1.973440E-01
Weekly Drinker-vs-Occasional Drinker
1.678030E-01
Weekly Drinker-vs-Social Drinker
7.198400E-01
Occasional Drinker-vs-Social Drinker
1.961800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.476400E-01
Normal-vs-Grade 2
5.421800E-02
Normal-vs-Grade 3
6.460100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.575190E-01
Grade 1-vs-Grade 3
5.692300E-02
Grade 1-vs-Grade 4
2.476400E-01
Grade 2-vs-Grade 3
2.262800E-01
Grade 2-vs-Grade 4
5.421800E-02
Grade 3-vs-Grade 4
6.460100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.440200E-01
Normal-vs-NonDiabetic
3.172000E-01
Diabetic-vs-NonDiabetic
2.177200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.860000E-01
Normal-vs-NoPancreatitis
3.622400E-01
Pancreatitis-vs-NoPancreatitis
9.348000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.616600E-01
Normal-vs-N1
2.749400E-01
N0-vs-N1
7.380100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.932010E-01
Normal-vs-TP53-NonMutant
3.032200E-01
TP53-Mutant-vs-TP53-NonMutant
1.879510E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
